Synopsys, Inc. $SNPS Shares Bought by Maplelane Capital LLC

Maplelane Capital LLC grew its holdings in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) by 50.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 123,000 shares of the semiconductor company’s stock after buying an additional 41,500 shares during the quarter. Synopsys accounts for about 1.7% of Maplelane Capital LLC’s investment portfolio, making the stock its 19th largest holding. Maplelane Capital LLC’s holdings in Synopsys were worth $48,767,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also made changes to their positions in the stock. China Universal Asset Management Co. Ltd. raised its stake in shares of Synopsys by 31.8% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 14,810 shares of the semiconductor company’s stock valued at $6,957,000 after purchasing an additional 3,575 shares in the last quarter. SeaTown Holdings Pte. Ltd. lifted its position in shares of Synopsys by 55.9% during the fourth quarter. SeaTown Holdings Pte. Ltd. now owns 22,300 shares of the semiconductor company’s stock worth $10,475,000 after purchasing an additional 8,000 shares during the last quarter. Norges Bank acquired a new position in Synopsys in the fourth quarter worth about $730,197,000. Douglas Lane & Associates LLC grew its stake in Synopsys by 5,701.2% in the fourth quarter. Douglas Lane & Associates LLC now owns 48,730 shares of the semiconductor company’s stock worth $22,889,000 after purchasing an additional 47,890 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. increased its holdings in Synopsys by 11.3% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 131,369 shares of the semiconductor company’s stock valued at $61,707,000 after buying an additional 13,320 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Rosenblatt Securities upped their price objective on Synopsys from $530.00 to $575.00 and gave the company a “buy” rating in a research note on Tuesday, May 26th. Stifel Nicolaus lifted their target price on Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Wells Fargo & Company boosted their price target on Synopsys from $505.00 to $535.00 and gave the company an “equal weight” rating in a report on Thursday, May 28th. Robert W. Baird set a $558.00 price target on Synopsys in a research report on Thursday, May 28th. Finally, Zacks Research upgraded Synopsys from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, June 30th. Two analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $570.06.

View Our Latest Stock Report on SNPS

Synopsys Price Performance

SNPS opened at $373.47 on Friday. The firm has a market cap of $71.51 billion, a price-to-earnings ratio of 86.45, a price-to-earnings-growth ratio of 2.19 and a beta of 1.22. Synopsys, Inc. has a fifty-two week low of $366.00 and a fifty-two week high of $651.73. The company’s 50-day moving average price is $456.13 and its 200 day moving average price is $455.25. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33.

Synopsys (NASDAQ:SNPSGet Free Report) last issued its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The firm had revenue of $2.28 billion for the quarter, compared to analysts’ expectations of $2.25 billion. During the same quarter last year, the company posted $3.67 earnings per share. Synopsys’s revenue was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, sell-side analysts expect that Synopsys, Inc. will post 10.65 earnings per share for the current year.

Insider Buying and Selling

In related news, CFO Shelagh Glaser sold 3,394 shares of the firm’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the sale, the chief financial officer owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the transaction, the chief executive officer owned 75,020 shares of the company’s stock, valued at $34,431,179.20. This represents a 16.29% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by corporate insiders.

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Read More

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.